Prevalence of mixed dyslipidemia among Australian patients undergoing lipid-modifying therapy

BACKGROUND: Few studies have assessed the prevalence of mixed dyslipidemia (MD) and the effectiveness of lipid-modifying therapy (LMT) for the treatment of abnormal levels of low-density lipoprotein cholesterol (LDL-C), triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C) in Australia...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Colquhoun, David, Chirovsky, Diana, Sazonov, Valsilisa, Cui, Yadong A, Ambegaonkar, Baishali
Médium: Artigo
Jazyk:Inglês
Vydáno: Pulsus Group Inc 2013
Témata:
Clinical Cardiology: Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3716499/
https://ncbi.nlm.nih.gov/pubmed/24294045
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky